Cash flows from operating activities: | |
Net income | 32.77M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Gain on sale of discontinued operations, net of tax | |
Gain on sale of product line | |
Depreciation and amortization | 14.06M |
Deferred income taxes | -719K |
Stock based compensation | 3.07M |
Loss on disposition of property, plant and equipment | 0 |
Changes in operating assets and liabilities: | |
Accounts receivable | -15.38M |
Inventories | -150K |
Taxes receivable | |
Accounts payable | 10.93M |
Accrued payroll and other compensation | 2.65M |
Accrued taxes | 2.1M |
Other, net | |
Net cash provided by operating activities | 47.42M |
Cash flows from investing activities: | |
Net proceeds from divestiture | 0 |
Receipt from acquisition net assets adjustment | |
Proceeds from sale of a product line | |
Capital expenditures | -19.03M |
Reimbursement of cash from leasing company | |
Increase in restricted cash | |
Net cash provided by investing activities | -120.13M |
Cash flows from financing activities: | |
Debt proceeds | 85M |
Debt repayments | -10.32M |
Common stock issued | 611K |
Net cash used for financing activities | 74.48M |
Effect of exchange rate changes on cash | -565K |
Increase (decrease) in cash and cash equivalents | 1.21M |
Cash and cash equivalents at beginning of period | 75.91M |
Cash and cash equivalents at end of period | 77.12M |